Confounding: An Introduction Epidemiology Supercourse Astana, July 2012 Philip la Fleur, RPh MSc(Epidem) Deputy Director, Center for Life Sciences

Slides:



Advertisements
Similar presentations
June 25, 2006 Propensity Score Adjustment in Survival Models Carolyn Rutter Group Health Cooperative AcademyHealth, Seattle WA.
Advertisements

Bias Lecture notes Sam Bracebridge.
Basic statistics.
M2 Medical Epidemiology
MARIEL LOPEZ & MARITZA RENEAU Foreign Languages. Warm-Up Identification and Classification of Outcome Medical condition Psychological or social problem.
Aging Farmers: Findings from the UC Davis Farmer Cohort Marc Schenker, Diane Mitchell, Tracey Armitage Western Center for Agricultural Health.
Oncology and Palliative Care: Promoting the Comfort and Cure Model Parag Bharadwaj, MD FAAHPM.
Presentations in this series 1.Introduction 2.Self-matching 3.Proxies 4.Intermediates 5.Instruments 6.Equipoise Avoiding Bias Due to Unmeasured Covariates.
Understanding real research 3. Assessment of risk.
Measures of Effect: An Introduction Epidemiology Supercourse Astana, July 2012 Philip la Fleur, RPh MSc(Epidem) Deputy Director, Center for Life Sciences.
Peking University Dayi Hu Sept 16, IHF,Beijing, 2005 Atrial Fibrillation in China.
Confounding And Interaction Dr. L. Jeyaseelan Department Of Biostatistics CMC, Vellore.
Critical Appraisal of an Article on Therapy. Why critical appraisal? Why therapy?
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July-August 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Journal Club Alcohol and Health: Current Evidence May-June 2006.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
THREE CONCEPTS ABOUT THE RELATIONSHIPS OF VARIABLES IN RESEARCH
Critical Appraisal of an Article by Dr. I. Selvaraj B. SC. ,M. B. B. S
CASE CONTROL STUDIES Dr. A. K. AVASARALA MBBS, M.D. PROFESSOR & HEAD DEPT OF COMMUNITY MEDICINE & EPIDEMIOLOGY PRATHIMA INSTITUTE OF MEDICAL SCIENCES,
Case Control Study Manish Chaudhary BPH, MPH
HSTAT1101: 27. oktober 2004 Odd Aalen
Lecture 8 Objective 20. Describe the elements of design of observational studies: case reports/series.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
EPIB-591 Screening Jean-François Boivin 29 September
Tim Wiemken PhD MPH CIC Assistant Professor Division of Infectious Diseases University of Louisville, Kentucky Confounding.
AETIOLOGY Case control studies (also RCT, cohort and ecological studies)
Evidence-Based Medicine 3 More Knowledge and Skills for Critical Reading Karen E. Schetzina, MD, MPH.
Lecture 6 Objective 16. Describe the elements of design of observational studies: (current) cohort studies (longitudinal studies). Discuss the advantages.
Mother and Child Health: Research Methods G.J.Ebrahim Editor Journal of Tropical Pediatrics, Oxford University Press.
Confounding. Objectives To define and discuss confounding To discuss methods of diagnosing confounding To define positive, negative and qualitative confounding.
Article Review Cara Carty 09-Mar-06. “Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of.
Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida,
Lecture 5 Objective 14. Describe the elements of design of experimental studies: clinical trials and community intervention trials. Discuss the advantages.
Case-control study Chihaya Koriyama August 17 (Lecture 1)
Design and Analysis of Clinical Study 2. Bias and Confounders Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Analytical epidemiology Disease frequency Study design: cohorts & case control Choice of a reference group Biases Alain Moren, 2006 Impact Causality Effect.
Literature Appraisal Effectiveness of Therapy. Measures of treatment effect Statistical significance Odds ratio Relative risk Absolute risk reduction.
Entering Multidimensional Space: Multiple Regression Peter T. Donnan Professor of Epidemiology and Biostatistics Statistics for Health Research.
PH 401: Meta-analysis Eunice Pyon, PharmD (718) , HS 506.
The Association between blood glucose and length of hospital stay due to Acute COPD exacerbation Yusuf Kasirye, Melissa Simpson, Naren Epperla, Steven.
Tim Wiemken PhD MPH CIC Assistant Professor Division of Infectious Diseases University of Louisville, Kentucky Confounding.
Medical Research: Validity, Bias, Confounds, Probability, P-value, and Power Kimberly Pendell.
Case-Control Study Duanping Liao, MD, Ph.D
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Clinical Epidemiology and Evidence-based Medicine Unit FKUI – RSCM
Incidence and prognosis of hepatocellular adenoma in Denmark Lars Bossen Departments of Hepatology and Gastroenterology and Clinical Epidemiology Aarhus.
Matching. Objectives Discuss methods of matching Discuss advantages and disadvantages of matching Discuss applications of matching Confounding residual.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
Reduced Lung Cancer Mortality Risk Among Breast Cancer Patients Treated With Anti- Estrogens Rapiti E et al. SABCS 2009;Abstract 35.
Headlines Introduction General concepts
Carina Signori, DO Journal Club August 2010 Macdonald, M. et al. Diabetes Care; Jun 2010; 33,
Pharmacy in Public Health: Introduction Course, date, etc. info.
Statin treatment and reduced risk of pneumonia in patients with diabetes EMW van de Garde, E Hak, P c Souverein, AW Hoes, JMM van den Bosch, HGM Leufkens.
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Epidemiological Methods
Epidemiology 503 Confounding.
Lecture 3: Introduction to confounding (part 1)
Presenter: Wen-Ching Lan Date: 2018/03/28
Measurements of Risk & Association …
Update from education committee
Entry, Randomization, and Follow-up of Patients in the Hypertension in the Very Elderly Trial Of the 461 patients who did not meet the protocol criteria,
Counterfactual models Time dependent confounding
Ob/Gyn Journal Club Notes
Alcohol, Other Drugs, and Health: Current Evidence
Effect Modifiers.
Basic statistics.
Alcohol, Other Drugs, and Health: Current Evidence May–June 2019
Presentation transcript:

Confounding: An Introduction Epidemiology Supercourse Astana, July 2012 Philip la Fleur, RPh MSc(Epidem) Deputy Director, Center for Life Sciences

Objectives Review why randomization is used and how it can minimize confounding Understand how to identify a confounder Understand the fundamental logic underlying adjusted analyses

Review: Why Randomize? Emerg Med J 2003;20:

Tadalafil Therapy for Pulmonary Arterial Hypertension (PAH). Circul 2009;119:2894

Definition of a Confounder For a variable to be a confounder it should meet three conditions: 1.The factor must be associated with the exposure being investigated 2.Must be independently associated with the outcome being investigated 3.Not be in the causal pathway between exposure and outcome.

Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome NEJM 2004;351:327-36

Understanding Confounding and Adjusting for Confounding; Qualitative Demonstration Treatment Group (N=100) – 80 young – 20 old Result = Control Group N=100 – 20 young – 80 old Treatment (apparently) Worked!

Treatment Group – 80 young – 20 old Control Group – 20 young – 80 old The Truth: RR of Treatment = 1.0 Risk of Death in Young = 10% Risk of Death in Old = 20% DeadAliveTotal Treated100 Control100 Total = = Overall Analysis (all patients)

Calculate Relative Risk DeadAliveTotal Treated Control Total Risk of Dying in Treated: 12/100 = 0.12 Risk of Dying in Control: 18/100 = 0.18 Relative Risk of Dying in Treated Compared to Control = 0.12/0.18 = 0.67

How do we solve this problem? Young Patients – Treatment – Control Old Patients – Treatment – Control

DeadAliveTotal Treated87280 Control21820 Total DeadAliveTotal Treated41620 Control Total Young Subjects Old Subjects Risk in Treatment Group: 8/80 = 0.1Risk in Treatment Group: 4/20 = 0.2 DeadAliveTotal Treated Control Total All Subjects Risk in Control Group: 10/100 = 0.1 Relative Risk = 1.0 Risk in Control Group: 16/80 = 0.2 Relative Risk = 1.0

Higher versus Lower Positive End-Expiratory Pressures in Patients with Acute Respiratory Distress Syndrome NEJM 2004;351:327-36

Definition of a Confounder For a variable to be a confounder it should meet three conditions: 1.The factor must be associated with the exposure being investigated 2.Must be independently associated with the outcome being investigated 3.Not be in the causal pathway between exposure and outcome. EXPOSURE (Truck Driving) OUTCOME (Lung Cancer) CONFOUNDER (Smoking)

Example: Do we have a confounder? Oral Contraceptive Use Cervical Cancer Age at first intercourse = CONFOUNDER?

Example: Do we have a confounder? Used OCNever used OC Cases Controls Odds Ratio = 1.9

Example: Do we have a confounder? Age at first intercourse was < 20 years Age at first intercourse was 20+ years Used OCNever Used OCUsed OCNever Used OC Cases Controls Estimated Odds Ratio = 1.0

Is it a Confounder? Test #1 1.The factor must be associated with the exposure being investigated 2.Must be independently associated with the outcome being investigated 3.Not be in the causal pathway between exposure and outcome. Oral Contraceptive Use Cervical Cancer Age at First Intercourse ?

Is it a Confounder? Test #1 Exposure Confounder Used OCNever Used OC Age at first intercourse <20 years100 (50%)50 (20%) Age at first intercourse 20+ years100 (50%)200 (80%) Total200 (100%)250 (100%) 20% of those who never used OC had an early age of intercourse 50% of those who used OC had an early age of intercourse

Is it a Confounder? Test #2 1.The factor must be associated with the exposure being investigated 2.Must be independently associated with the outcome being investigated 3.Not be in the causal pathway between exposure and outcome. Oral Contraceptive Use Cervical Cancer Age at First Intercourse ?

Is it a Confounder? Test #2 Confounder Age at first intercourse <20 years Age at first intercourse 20+ years Cases Controls Odds Ratio= 8.0

Is it a Confounder? Test #3 1.The factor must be associated with the exposure being investigated 2.Must be independently associated with the outcome being investigated 3.Not be in the causal pathway between exposure and outcome. Oral Contraceptive Use Cervical Cancer Age at First Intercourse

Confounding Relative Risk in the entire population Relative Risk in young people Relative Risk in old people Adjusted Relative Risk Scenario 1No confounding3.0 Scenario 2Confounding Scenario 3Confounding1.91.0

End The End

References/Bibliography 1.Last JM. A Dictionary of Epidemiology, 4th ed. Oxford University Press, Guyatt G et al. Users’ Guides to the Medical Literature, 2nd ed. McGraw Hill, Kennedy CC et al Tips for Teachers of EBM: Adjusting for Prognostic Imbalances (Confounding variables) in studies of therapy or harm. J Gen Int Med 23(3): (and associated lecture by G. Guyatt) 4.Streiner GR, Norman DL, PDQ Epidemiology. 2nd Ed. BC Decker Inc. 1998